Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA staff recommends limited use of Daiichi's blood thinner
FDA staff recommends limited use of Daiichi's blood thinner
FDA staff recommends limited use of Daiichi's blood thinner
Submitted by
admin
on October 28, 2014 - 11:34am
Source:
Yahoo/Reuters
News Tags:
Daiichi Sankyo
FDA
bloodthinners
edoxaban
atrial fibrillation
Headline:
FDA staff recommends limited use of Daiichi's blood thinner
Do Not Allow Advertisers to Use My Personal information
